Burleson & Co’s CME Group CME Stock Holding History

Burleson & Co’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$1K	–	442
2022 Q1	$1K	Buy	+3	New	+$705	﹤0.01%	350

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Burleson & Co's CME Position: Q2 2022 in Review

Burleson & Co sold out of CME Group (CME) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.

Burleson & Co first reported a position in CME in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

Burleson & Co reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
Burleson & Co sold 3 CME Group shares in Q2 2022, an estimated $1K.
Burleson & Co first reported a position in CME Group in Q1 2022 and held it in 1 quarter.
Burleson & Co's CME Group position peaked at $1K in Q1 2022.
1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on Burleson & Co's 13F filing for Q2 2022, filed 13 Jul 2022.